scispace - formally typeset
J

Jason L. Dragoo

Researcher at University of Colorado Denver

Publications -  146
Citations -  8537

Jason L. Dragoo is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Anterior cruciate ligament & Platelet-rich plasma. The author has an hindex of 41, co-authored 141 publications receiving 7016 citations. Previous affiliations of Jason L. Dragoo include Stanford University & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Comparison of Multi-Lineage Cells from Human Adipose Tissue and Bone Marrow

TL;DR: This study is the first comparison of PLA cells and MSCs isolated from the same patient, and no significant differences were observed for yield of adherent stromal cells, growth kinetics, cell senescence, multi-lineage differentiation capacity, and gene transduction efficiency.
Journal ArticleDOI

Comparison of Growth Factor and Platelet Concentration From Commercial Platelet-Rich Plasma Separation Systems

TL;DR: The GPS III and Magellan concentrate leukocyte-rich PRP, which results in increased concentrations of WBCs,PDGF-αβ, PDGF-ββ, and VEGF as compared with the leukocytes-poor PRP from Cascade, which was comparable with Magellan but significantly higher than GPS III.
Journal ArticleDOI

Bone induction by BMP-2 transduced stem cells derived from human fat

TL;DR: This study examines the osteogenic potential of PLAs and bone marrow aspirate cells (BMAs) when exposed to either recombinant human bone morphogenetic protein (BMP)‐2 (rh‐BMP‐2) or adenovirus containing BMP‐ 2 cDNA (Ad‐B MP‐2).
Journal ArticleDOI

Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads.

TL;DR: Radiological and histological analysis indicated that the PLA cells induced into the chondrogenic phenotype had the histological appearance of hyaline cartilage, which may prove to be useful for the treatment of osteochondral defects.
Journal ArticleDOI

Platelet-Rich Plasma as a Treatment for Patellar Tendinopathy A Double-Blind, Randomized Controlled Trial

TL;DR: A therapeutic regimen of standardized eccentric exercise and ultrasound-guided leukocyte-rich PRP injection with DN accelerates the recovery from patellar tendinopathy relative to exercise and ultrasound-guided DN alone, but the apparent benefit of PRP dissipates over time.